First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sees Strong Trading Volume – Still a Buy?

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw unusually-high trading volume on Monday . Approximately 42,532 shares were traded during trading, an increase of 59% from the previous session’s volume of 26,808 shares.The stock last traded at $179.20 and had previously closed at $178.69.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

The company has a fifty day simple moving average of $171.10 and a two-hundred day simple moving average of $162.39. The firm has a market capitalization of $1.32 billion, a PE ratio of 17.20 and a beta of 0.86.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Several large investors have recently modified their holdings of the business. Maia Wealth LLC raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.3% in the third quarter. Maia Wealth LLC now owns 4,725 shares of the company’s stock worth $795,000 after purchasing an additional 60 shares in the last quarter. Gateway Wealth Partners LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 3.8% during the 2nd quarter. Gateway Wealth Partners LLC now owns 1,656 shares of the company’s stock worth $255,000 after acquiring an additional 61 shares in the last quarter. WealthShield Partners LLC lifted its position in First Trust NYSE Arca Biotechnology Index Fund by 1.8% during the second quarter. WealthShield Partners LLC now owns 3,714 shares of the company’s stock valued at $572,000 after acquiring an additional 66 shares during the last quarter. TD Capital Management LLC boosted its stake in First Trust NYSE Arca Biotechnology Index Fund by 6.4% in the second quarter. TD Capital Management LLC now owns 1,141 shares of the company’s stock valued at $176,000 after acquiring an additional 69 shares in the last quarter. Finally, Campbell Wealth Management grew its holdings in First Trust NYSE Arca Biotechnology Index Fund by 3.5% in the third quarter. Campbell Wealth Management now owns 2,617 shares of the company’s stock worth $450,000 after purchasing an additional 88 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.